Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia

被引：22
|
作者：
Park, Jae H. [1 ]
Chung, Stephen S. [1 ]
Durham, Benjamin [2 ]
Chung, Young Rock [3 ]
Scott, Sasinya [2 ]
Getta, Bartlomiej [2 ]
Kim, Eunhee [2 ]
Saven, Alan [4 ]
Stone, Richard M. [5 ]
Rai, Kanti R. [6 ]
Grever, Michael R. [7 ]
Altman, Jessica K. [8 ]
Rosen, Neal [9 ]
Levine, Ross L. [2 ]
Berger, Michael [10 ]
Tallman, Martin S. [1 ]
Abdel-Wahab, Omar [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[4] Scripps Hlth, La Jolla, CA USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[6] North Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA
[7] Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA
[8] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[9] Mem Sloan Kettering Canc Ctr, Pharmacol, New York, NY 10021 USA
[10] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.682.682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib
    Sascha, Dietrich
    Pircher, Andreas
    Andrulis, Mindaugas
    Ellert, Elena
    Peyrade, Frederic
    Wendtner, Clemens-Martin
    Follows, George A.
    Dyer, Martin J. S.
    Elter, Thomas
    Zeiser, Robert
    Gaehler, Anita
    Herrmann, Michael
    Herold, Michael
    Dearden, Claire
    Glimm, Hanno
    Hallek, Michael
    Ho, Anthony D.
    Steurer, Michael
    Zenz, Thorsten
    BLOOD, 2014, 124 (21)
  • [22] Rapid Response to Vemurafenib in a Heavily Pretreated Patient With Hairy Cell Leukemia and a BRAF Mutation
    Munoz, Javier
    Schlette, Ellen
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : E351 - E352
  • [23] Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Harding, James J.
    Catalanotti, Federica
    Yaqubie, Amin
    McDermott, Gregory C.
    Kersellius, Romona
    Merghoub, Taha
    Carvajal, Richard D.
    D'Angelo, Sandra P.
    Dickson, Mark Andrew
    Schwartz, Gary K.
    Wolchok, Jedd D.
    Berger, Michael F.
    Solit, David B.
    Chapman, Paul B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
    Tiacci, E.
    Park, J. H.
    De Carolis, L.
    Chung, S. S.
    Broccoli, A.
    Scott, S.
    Zaja, F.
    Devlin, S.
    Pulsoni, A.
    Chung, Y. R.
    Cimminiello, M.
    Kim, E.
    Rossi, D.
    Stone, R. M.
    Motta, G.
    Saven, A.
    Varettoni, M.
    Altman, J. K.
    Anastasia, A.
    Grever, M. R.
    Ambrosetti, A.
    Rai, K. R.
    Fraticelli, V.
    Lacouture, M. E.
    Carella, A. M.
    Levine, R. L.
    Leoni, P.
    Rambaldi, A.
    Falzetti, F.
    Ascani, S.
    Capponi, M.
    Martelli, M. P.
    Park, C. Y.
    Pileri, S. A.
    Rosen, N.
    Foa, R.
    Berger, M. F.
    Zinzani, P. L.
    Abdel-Wahab, O.
    Falini, B.
    Tallman, M. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18): : 1733 - 1747
  • [25] Immune reconstitution in patients with classical hairy cell leukemia during treatment with the BRAF inhibitor vemurafenib
    Konrat, J.
    Roiss, M.
    Rosler, W.
    Meier-Abt, F.
    Widmer, C. C.
    Balabanov, S.
    Manz, M. G.
    Zenz, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 38 - 39
  • [26] Targeting resistance pathways in BRAF-mutant pediatric gliomas
    Yao, Tsun-Wen Sheena
    Yoshida, Yasuyuki
    Zhang, Jie
    Ozawa, Tomoko
    James, David
    Nicolaides, Theodore
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Efficacy of Vemurafenib in Hairy-Cell Leukemia
    Samuel, Jesvin
    Macip, Salvador
    Dyer, Martin J. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (03): : 286 - 288
  • [28] TARGETING RESISTANCE PATHWAYS IN BRAF-MUTANT PEDIATRIC GLIOMAS
    Nicolaides, Theodore
    Yao, Tsun Wen
    Yoshida, Yasuyuki
    Zhang, Jie
    Ozawa, Tomoko
    James, David
    NEURO-ONCOLOGY, 2014, 16
  • [29] TARGETING RESISTANCE PATHWAYS IN BRAF-MUTANT PEDIATRIC GLIOMAS
    Yao, Tsun-Wen
    Yoshida, Yasuyuki
    Zhang, Jie
    Ozawa, Tomoko
    James, David
    Nicolaides, Theodore
    NEURO-ONCOLOGY, 2014, 16 : 40 - 41
  • [30] VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid cancer
    Chen, Shitu
    Su, Xingyun
    Jiang, Xiaoxia
    Zhang, Tuo
    Min, Irene
    Ding, Yongfeng
    Wang, Xumeng
    Mao, Zhuochao
    Cao, Jiang
    Teng, Xiaodong
    Fahey, Thomas J., III
    Wang, Weibin
    Teng, Lisong
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 441 - 451
12345